Babyl & novo nordisk partner to provide an innovative approach to diabetes awareness and care in rwanda

Austin, texas & kigali, rwanda & london--( business wire )--babyl, a subsidiary of babylon (nyse: bbln), and novo nordisk announced today that they have entered an innovative partnership to contribute to the expansion of diabetes awareness and care in rwanda. drawing on novo nordisk's expertise and mission to drive change to defeat diabetes and babyl's existing infrastructure and experience in delivering digital health services at scale in rwanda, this new joint initiative aims to improve awareness, care and management of diabetes through community engagement, skills building and use of babyl's advanced digital technology.
BBLN Ratings Summary
BBLN Quant Ranking